154 participants
A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer
- Study Type:
- INTERVENTIONAL
- Last Updated:
- 2026-05-22
- Start Date:
- 2023-09-28
- Completion:
- 2026-02-19
Conditions
- Androgen-Independent Prostatic Cancer
- Androgen-Independent Prostatic Neoplasms
- Prostate Cancer Recurrent
- Androgen-Insensitive Prostatic Cance
- Androgen-Resistant Prostatic Cancer
- Hormone Refractory Prostatic Cancer
- Immunotherapy
- Immune Checkpoint Inhibitor
- Inhibitory Checkpoint Molecule
Interventions
- BIOLOGICAL
- DRUG
No Results Yet